Use of chromium histidinate for treatment of cardiometabolic disorders
AssigneeNutrition 21
InventorsVijaya Juturu, James R. Komorowski
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising chromium and histidine, chromium histidinate complexes, or combinations thereof, to the individual.
Claims17
A method for reducing free fatty acid levels in a subject in need thereof, comprising:
- identifying a subject with elevated free fatty acid levels;
- and
- providing a therapeutically effective amount of a composition comprising chromium and histidine, a chromium histidinate complex, or a combination thereof, to said subject.
A method for reducing cortisol levels in a subject in need thereof, comprising:
- identifying a subject with elevated cortisol levels;
- and
- providing a therapeutically effective amount of a composition comprising chromium and histidine, a chromium histidinate complex, or a combination thereof, to said subject.
A method for reducing free fatty acid levels in a subject in need thereof, comprising:
- identifying a subject with elevated free fatty acid levels;
- and
- providing a therapeutically effective amount of a composition consisting essentially of a pharmaceutically acceptable carrier, chromium and histidine, a chromium histidinate complex, or a combination thereof, to said subject.
-20. (canceled)
Dependencies are inferred from the claim text.